In contrast, Xiong et al. demonstrated that miR-410-3p impaired gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy 23. Here, HMGB1 is linked to pancreatic ductal adenocarcinoma.